Literature DB >> 6163708

Transfer of interferon-induced viral resistance from human leukocytes to other cell types.

J E Blalock, D A Weigent, M P Langford, G J Stanton.   

Abstract

Nonsensitized human leukocytes cocultured with various xenogeneic epithelioid and fibroblastic cells produced human leukocyte interferon and shortly thereafter transferred antiviral activity to the xenogeneic cells. Antiviral activity in the cocultured xenogeneic cells was not due to cell-mediated cytotoxicity as measured by specific 51Cr release and staining with vital dyes. The transfer of antiviral activity from leukocytes to xenogeneic cells was blocked by rabbit antiserum to human leukocyte interferon. Transferred viral resistance failed to develop in actinomycin D-treated xenogeneic cells, even though these cells induced human leukocyte interferon. Based on these findings, it appears that interferon made in the cocultures acts on the leukocytes to effect the transfer of interferon-induced viral resistance to the xenogenic cells, possibly by transmission of an inducer for the antiviral state. These studies strongly suggest a new and efficient host defense against virus infection which does not require killing of noninfected or recently infected cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6163708      PMCID: PMC551125          DOI: 10.1128/iai.29.2.356-360.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells.

Authors:  J E Blalock; M P Langford; J Georgiades; G J Stanton
Journal:  Cell Immunol       Date:  1979-03-01       Impact factor: 4.868

2.  A small fraction of cells communicates the maximal interferon sensitivity to a population.

Authors:  J E Blalock
Journal:  Proc Soc Exp Biol Med       Date:  1979-10

3.  Mechanisms of interferon induced transfer of viral resistance between animal cells.

Authors:  J E Blalock; S Baron
Journal:  J Gen Virol       Date:  1979-02       Impact factor: 3.891

4.  Efficient transfer of interferon-induced virus resistance between human cells.

Authors:  J E Blalock; G J Stanton
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

5.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes.

Authors:  M P Langford; G J Stanton; H M Johnson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

7.  Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.

Authors:  R M Welsh
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

8.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.

Authors:  G Trinchieri; D Santoli; R R Dee; B B Knowles
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

  9 in total
  2 in total

1.  Human B lymphocytes produce leukocyte interferon after interaction with foreign cells.

Authors:  D A Weigent; M P Langford; E M Smith; J E Blalock; G J Stanton
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

2.  Streptococcus pneumoniae cocultured with fibroblasts enhances both interferon production and cytotoxic activity by lymphocytes.

Authors:  D A Weigent; S Baron; G J Stanton
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.